Toggle navigation
Home
Search
Services
Blog
Contact
About
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan
Cicerodx, Inc., Huntington Beach, CA, United States
Search grants from Dan Angress
Search grants from Cicerodx, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanism of manganese-induced impairment of astrocytic glutamate transporters
Role of the protein SUMOylation pathway in Ras-driven oncogenesis
Role of Lipid Droplet Proteins in Islet Function in Diabetes and Obesity
Urological Research Training Program
Social Mobility, Race, and Women's Mental Health
Recently added grants:
Neutrophil plasticity in autoimmune disease
Enhance Arthroplasty Research through Electronic Health Records and Nlp-Enabled Informatics
H. pylori-induced Inflammation and Gastric Cancer
Understanding the mechanism of action for anticancer sulfonamides that target splicing
Directing the metabolic fate of CAR T cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
4R44HD097750-02
Application #
10028286
Study Section
Special Emphasis Panel (ZHD1)
Program Officer
Tingen, Candace M
Project Start
2020-02-11
Project End
2022-01-31
Budget Start
2020-02-11
Budget End
2021-01-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Institution
Name
Cicerodx, Inc.
Department
Type
DUNS #
081007068
City
Huntington Beach
State
CA
Country
United States
Zip Code
92649
Related projects
NIH 2020
R44 HD
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan / Cicerodx, Inc.
NIH 2019
R44 HD
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan / Cicerodx, Inc.
Comments
Be the first to comment on Dan Angress's grant